Results 61 to 70 of about 90,442 (294)

Maternal and perinatal results of preeclamsia before 31 weeks of gestation at clinica maternidad Rafael calvo cartagena, colombia

Revista Ciencias Biomédicas, 2011
Hypertensive disorders in pregnancy are associated to a high rate of maternal andperinatal morbidity and mortality.Objective: To describe maternal and perinatal results in pre-eclamptic women withdelivery before 36 weeks of gestation.Methods: A ...
Mogollon-Saker Sandra Patricia, Salcedo-Ramos Francisco, Ramos-Clason Enrique Carlos   +2 more
doaj  

Maternal deaths in Australia 2006-2010 [PDF]

, 2014
Summary: Maternal deaths in Australia 2006–2010 provides a summary of statistics on maternal mortality in Australia to inform safety and quality of maternity care in Australia, and provides good practice guidance from members of the National Maternal ...

core  

Could a simple antenatal package combining micronutritional supplementation with presumptive treatment of infection prevent maternal deaths in sub-Saharan Africa? [PDF]

, 2007
BACKGROUND: Reducing maternal mortality is a key goal of international development. Our objective was to determine the potential impact on maternal mortality across sub-Saharan Africa of a combination of dietary supplementation and presumptive treatment ...
Collin, Simon M, Pittrof Rudiger, Baggaley, Rebecca F, Rebecca F Baggaley, Collin, SM, Filippi, Veronique, Collin Simon M, Veronique Filippi, Baggaley Rebecca F, Pittrof, Rudiger, Filippi, V, Baggaley, RF, Rudiger Pittrof, Filippi Veronique, Simon M Collin, Pittrof, R   +15 more
core   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Maternal deaths in Australia 2008–2012 [PDF]

, 2015
This is the 16th report on women in Australia who die in association with pregnancy and childbirth. Authored by AIHW, Humphrey MD, Bonello MR, Chughtai A, Macaldowie A, Harris K and Chambers GM.
Michelle Bonello
core  

Humans are not unique: difficult birth is common in placental mammals

Biological Reviews, EarlyView.
ABSTRACT Human childbirth is widely presumed to be uniquely difficult and dangerous compared to birth in other mammals. Tight fetopelvic proportions can result in obstructed labour and contribute to high rates of maternal and neonatal mortality. Ideas summarised under the ‘obstetrical dilemma’ have contributed to this assumption by explaining difficult
Nicole D. S. Grunstra
wiley   +1 more source

Maternal Near Miss (Severe Morbidity) at Sisaket Hospital

Thai Journal of Obstetrics and Gynaecology, 2012
Objective:To study the incidence of maternal near miss cases (severe morbidity), their near miss events and obstetric outcomes at Sisaket Hospital.Materials and Methods: This prospective cross-sectional study was conducted between October 1st ...
Wanchai Wianwiset
doaj  

Maternal health improvement through root cause analysis of severe maternal morbidity (maternal near miss) in Isfahan, Iran

Journal of Education and Health Promotion, 2020
INTRODUCTION: Investigating severe maternal morbidity and near-miss cases are applied internationally as a new indicator to examine the quality of maternal care and as an effective strategy to reduce maternal mortality.
Sepideh Zhali, Shahnaz Kohan, Azar Danesh Shahraki, Marjan Beigi   +3 more
doaj   +1 more source

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

Clinical Pharmacology &Therapeutics, EarlyView.
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary, Robert Bies, Osei Boateng, Rachel Daley, Pierre Gashema, Mili Karina, Emily Njuguna, Sharon Nachman, Nathaniel Nkrumah, Carolyne Odula, Andrew Owen, Ethel D. Weld, Prajith Venkatasubramanian, Adeniyi Olagunju, on behalf of the Community of Practice for Long‐acting Therapeutics for Maternal and Paediatric Health, Rana Abutaima, Dorothy Akongo, Abdulnaser Alsharaa, Moherndran Archary, Shakir Atoyebi, Benoit Bestgen, Robert Bies, Osei Boateng, Andrew Butler, Edmund Capparelli, Rachel Daley, Layla Davies, Joelle Dountio, Henry Enzama, Pierre Gashema, Katila George, Dan Hawcutt, Rene Holm, Patrick Gad Iradukunda, Elodie Jambert, Mili Karina, Linda Lewis, Grace Miheso, Sebastien Morin, Andrew Morrison, Sharon Nachman, Shadia Nakalema, Emily Njunga, Nathaniel Nkrumah, Carolyne Odula‐Obonyo, Brenda Okware, Adeniyi Olagunju, Andrew Owen, Martina Penazzato, Natella Rakhmanina, Mphako Brighton Ratlabyana, Rachel Scott, Kimberly Struble, Andre‐Marie Tchouatieu, Catherine Unsworth, Prajith Venkatasubramanian, Catriona Waitt, Ethel Weld, Janine Winterbottom, Leena Zino   +59 more
wiley   +1 more source

How should we measure severe maternal morbidity associated with pregnancy and birth?

, 2019
As maternal mortality rates in developed countries fall, there is an increasing focus on measures of severe maternal morbidity (SMM) as clinical indicators.
DA Ellwood, Ellwood, DA
core   +1 more source